News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Black Diamond Therapeutics, Inc
Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
September 23, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
September 22, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
September 14, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 06, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
June 01, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
May 29, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Changes to Board of Directors
April 11, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
April 07, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
April 03, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 12, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024
March 05, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
January 04, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
December 13, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
November 07, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 06, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535
October 14, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces CEO Transition
September 18, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
GTHX
Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer
September 11, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
September 05, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
June 29, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
June 28, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families
June 27, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer
June 13, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.